Insight Molecular Diagnostics (IMDX) Asset Writedowns and Impairment (2020 - 2024)
Insight Molecular Diagnostics (IMDX) posted Asset Writedowns and Impairment of $36.9 million for Q4 2024, up 922600.0% sequentially from -$4000.0 in Q4 2023, and up 922600.0% YoY from N/an in Q1 2024.
Insight Molecular Diagnostics (IMDX) Asset Writedowns and Impairment (2020 - 2024) Analysis & Trends
Insight Molecular Diagnostics has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $36.9 million in Q4 2024.
- Quarterly Asset Writedowns and Impairment rose 922600.0% year-over-year to $36.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $38.7 million (up 472.1% YoY) and the FY2025 annual result came in at $14.6 million, down 65.16% from the prior year.
- Asset Writedowns and Impairment grew to $36.9 million in Q4 2024 per IMDX's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $36.9 million in Q4 2024 and troughed at -$334000.0 in Q3 2020.
- A 3-year average of $5.5 million and a median of $333500.0 in 2020 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 922600.0% in 2024, down 922600.0% in 2024.
- Over 3 years, Asset Writedowns and Impairment stood at $334000.0 in 2020, then sank by 101.2% to -$4000.0 in 2023, then soared by 922600.0% to $36.9 million in 2024.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $36.9 million, -$4000.0, and $1.8 million for Q4 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 36.90 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Dec 31, 2023 | -4,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | 1.81 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | -50,000.00 |
| Jun 30, 2023 | -50,000.00 |
| Mar 31, 2023 | 5.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2020 | 334,000.00 |
| Dec 31, 2020 | 334,000.00 |
| Sep 30, 2020 | -334,000.00 |
| Sep 30, 2020 | -334,000.00 |
| Jun 30, 2020 | 333,000.00 |
| Jun 30, 2020 | 333,000.00 |